UBS raises its recommendation on Aegon from 'hold' to 'buy', despite a slightly lowered price target from 6.65 to 6.55 euros, a new target that leaves 12% upside potential for the Dutch insurer's stock.

It's time to buy the downturn", says the broker, who points to an overall yield of 9% higher than that of the sector as a whole, and considers a share buyback program of 100 million euros possible with the publication of Q3 2024 results.

Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.